Oxford University COVID-19 Vaccine trials resume in the UK, India and Japan, but on hold in the US

AstraZeneca and Oxford University’s experimental COVID-19 vaccine clinical trials have resumed in Japan. The trials were put on a hold due to the illness of a British volunteer. On September 6, a study participant felt ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis.

AstraZeneca and Oxford University’s experimental COVID-19 vaccine clinical trials have resumed in Japan. The trials were put on a hold due to the illness of a British volunteer. On September 6,  a study participant felt ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis.

The British drugmaker said on Friday the early-to-mid-stage trial for the vaccine against the novel Coronavirus resumed in Japan after consultations with the national health regulator, the Japanese Pharmaceuticals and Medical Devices Agency.

Advertisement

Trials in the UK, Brazil, South Africa, and India had already restarted, but US trials remain paused as regulators widened their probe, Reuters reported on Wednesday, while discussions with US authorities continue.

However, this incident draws focus on the safety of candidates being developed in the race for a successful vaccine against the illness caused by the novel Coronavirus which has claimed more than a million lives globally.

The US Food and Drug Administration (FDA) broadened its investigation of the illness in the volunteer and would look at data from earlier trials of similar vaccines developed by the same scientists.

In Friday’s statement, AstraZeneca stressed that the safety of the participants was of “paramount importance” and that it was applying the highest standards of conduct in trials.